We identified a KMT2A-AFF1:RUNX1:CASP9 cascade, where RUNX1 acts as an intermediate repressor of CASP9. Although CASP9 is mostly regulated on the protein level, subtle impacts on the expression of the CASP9 gene could influence leukemia survival over the longer term. This evidence concerns the gene KMT2A and leukemia.